Caelus Lifesciences IP v Pendulum Therapeutics (CFI, UPC_CFI_1615/2026, 20 October 2026)

Date	20 October 2026
Court	CFI
Division	The Hague (NL) Local Division
Type of action	Application for provisional measures
Case number(s)	UPC_CFI_1615/2026
Registry reference	UPC-CFI-0001615/2026
Parties	Caelus Lifesciences IP B.V. v. Pendulum Therapeutics Inc.; iHerb Netherlands B.V.
Language	English

Official decision (PDF) · UPC registry entry

Case timeline

8 October 2026 : Caelus Lifesciences IP v Pendulum Therapeutics (CFI, UPC_CFI_1615/2026, 8 October 2026) UPC-CFI-0001615/2026

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 1 November 2026

Our analysis

Summary

In an order of 20 October 2026 (UPC_CFI_1615/2026) under Rule 353 RoP, the single judge of The Hague Local Division rectifies point 5.4 of his provisional measures order of 8 October 2026, which, copying the application, covered iHerb websites in all EPC states where the patent is in force. Publication is limited to UPC states where the patent is in force and to Switzerland: nothing in the order or the application indicated an extension to other states (Turkey, Spain, the UK and Poland in this case). The judge observes that this extension, buried in an ancillary request, should not be rewarded, whether intentional or not.

Provisions applied

UPC Agreement: Article 80
Rules of Procedure: Rule 353

Related decisions

The Hague Local Division, 8 October 2026, UPC_CFI_1615/2026, Caelus Lifesciences IP v Pendulum Therapeutics: provisional measures.

Prepared by Dhenne Avocats from the official decision, consulted on 1 November 2026. The database is updated every week, on Friday. Only the official text is authoritative.

Going further

Lexicon: Provisional and protective measures

Source and translations

Official source: Unified Patent Court registry link recorded in the record
Original language: English from the language of proceedings
Translation available: no translation recorded the firm’s French record is a summary, not a translation
Date checked: not recorded

Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

UPC_CFI_1615/2026 official number

Follow this case

Parties

claimantCaelus Lifesciences IP B.V.2 decisions in the corpus Follow this party
defendantPendulum Therapeutics Inc.2 decisions in the corpus Follow this party
defendantiHerb Netherlands B.V.2 decisions in the corpus Follow this party

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

8 October 2026 Caelus Lifesciences IP v Pendulum Therapeutics (CFI, UPC_CFI_1615/2026, 8 October 2026) Application for provisional measures · UPC_CFI_1615/2026
La division locale de La Haye fait interdire à titre provisoire, sur le territoire de la JUB et en Suisse, la commercialisation de probiotiques contenant Eubacterium hallii destinés à la résistance à l’insuline, en jugeant plus probable qu’improbable que le brevet de seconde application thérapeutique est valable et con…
20 October 2026 Caelus Lifesciences IP v Pendulum Therapeutics (CFI, UPC_CFI_1615/2026, 20 October 2026) Application for provisional measures · UPC_CFI_1615/2026

What the record states

Nature of the act: Application for provisional measures
Outcome (Dhenne Avocats summary): Sur demande des défenderesses, le juge rectifie la mesure de publication de l’ordonnance du 8 octobre 2026 pour la limiter aux sites iHerb des États de la JUB où le brevet est en vigueur et de la Suisse, à l’exclusion des autres États parties à la CBE.
Appeal: No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance: First-instance decision, whether it has become final is not recorded.

Related decisions cited in the analyses

Caelus Lifesciences IP v Pendulum Therapeutics (CFI, UPC_CFI_1615/2026, 8 October 2026) cited in this record

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.